---
title: Improve balance with motor imagery
nct_id: NCT06154356
phase: NA
status: RECRUITING
sponsor: Karamanoğlu Mehmetbey University
study_type: INTERVENTIONAL
canonical_url: "https://parkinsonspathways.com/trial/NCT06154356"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT06154356"
last_fetched: "2026-05-10T14:02:54.916Z"
source: "Parkinson's Pathways (curated)"
---
# Improve balance with motor imagery

**Goal (in five words):** Improve balance with motor imagery

**Official Title:** Effect of Action Observation and Motor Imagery Therapy on Balance, Functional Status and Quality of Life in Parkinson's Disease, Randomized Controlled Trial

**Trial ID:** [NCT06154356](https://clinicaltrials.gov/study/NCT06154356)

## Key Facts

- **Phase:** NA
- **Status:** RECRUITING
- **Study Type:** INTERVENTIONAL
- **Sponsor:** Karamanoğlu Mehmetbey University
- **Target Enrollment:** 54 participants
- **Start Date:** 2023-12-14
- **Completion Date:** 2026-06
- **Conditions:** Parkinson's Disease
- **Interventions:** Action observation and motor imagery therapy for rehabilitation, Sham action observation and motor imagery therapy for rehabilitation
- **Intervention Types:** OTHER

## Summary For Families

They are testing whether watching everyday movements and mentally rehearsing them can improve balance, daily function, and overall quality of life for people with Parkinson's. The therapy uses action observation and motor imagery, meaning you watch actions and vividly imagine doing them to activate the brain's motor networks and strengthen motor planning and balance without physical strain, while a sham version uses non-matching or neutral stimuli as a control. Because it is a non-drug, brain-based rehearsal method, it can complement usual physical therapy and be used alongside Parkinson's medications. The trial is looking for adults 18 to 65 with Parkinson's at Hoehn and Yahr stages 1 to 3 who can follow simple instructions, and it excludes people with major cognitive, severe vision or hearing problems, uncontrolled heart or lung disease, or musculoskeletal issues that limit movement.

## Eligibility

- **Minimum age:** 18 Years
- **Maximum age:** 65 Years
- **Sex:** ALL

### Full Criteria

```
Inclusion Criteria:

* Patients with a diagnosis of Parkinson's Disease
* Hoehn and Yahr Stage 1-3

Exclusion Criteria:

* Patients with cognitive dysfunction (those who cannot follow simple verbal instructions)
* Patients with severe hearing problems
* Patients with severe vision problems
* Patients with additional musculoskeletal system pathology that will affect physical performance (such as amputation, severe joint mobility limitation, peripheral nerve damage)
* Patients with uncontrolled hypertension and diabetes mellitus
* Patients with a history of symptomatic lung disease (such as asthma, chronic obstructive pulmonary disease, emphysema)
* Patients with a history of symptomatic cardiac disease (such as coronary artery disease, arrhythmia, heart failure)
```

## Locations (1)

- Karaman Training and Research Hospital, Karaman, Karaman, Turkey (Türkiye) _(37.1811, 33.2150)_
  - Yurdagul Bahran Mustu, MD. — (CONTACT) — +90 338 226 3228 — yurdagulbahran@gmail.com
  - Aynur Basaran, MD, Prof. — (CONTACT) — +90 338 226 3225 — aynurbasaran@gmail.com

## Central Contacts

- Yurdagul Bahran Mustu, MD. — (CONTACT) — +90 506 209 76 72 — yurdagulbahran@gmail.com
- Aynur Basaran, MD, Prof. — (CONTACT) — aynurbasaran@gmail.com

---

*Canonical: https://parkinsonspathways.com/trial/NCT06154356*  
*HTML version: https://parkinsonspathways.com/trial/NCT06154356*  
*Source data: https://clinicaltrials.gov/study/NCT06154356*